| Net income (loss) | 649K |
| Loss (income) from discontinued operations | |
| Depreciation and amortization | |
| Accretion of financing instruments | |
| Financing costs in for stock issued in connection with Convertible Note Payable | |
| Change in fair value of derivative liabilities | 368K |
| Gain on sale of fixed assets | |
| Compensation expense for consulting services | |
| Compensation expense for employee stock options | |
| Accounts receivable | |
| Inventories | -324K |
| Other current assets | 17K |
| Security deposits and other assets | 0 |
| Accounts payable | -640K |
| Accrued expenses and other liabilities | -93K |
| Net cash provided by (used in) operating activities - continuing operations | -526K |
| Net cash provided from operating activities - discontinued operations | |
| Net cash provided by operating activities | |
| Purchase of property and equipment | -41K |
| Proceeds from sale of property and equipment | |
| Net cash used in investing activities - continuing operations | |
| Net cash used in investing activities - discontinued operations | |
| Net cash used in investing activities | -41K |
| Proceeds from notes payable | |
| Payments under capital lease obligations | -39K |
| Net cash (used in) provided by financing activities - continuing operations | |
| Net cash provided by financing activities - discontinued operations | |
| Net cash (used in) provided by financing activities | 264K |
| Net increase in cash | -303K |
| Increase in cash, discontinued operations | |
| Cash at beginning of period, continuing operations | 395K |
| Cash at end of period, continuing operations | 92K |